View source for 18536739. SYSTEM AND METHODS FOR THE TREATMENT OF WOUNDS WITH NEGATIVE PRESSURE AND INSTILLATION OF PEROXIDE PYRUVIC ACID simplified abstract (3M INNOVATIVE PROPERTIES COMPANY)

=SYSTEM AND METHODS FOR THE TREATMENT OF WOUNDS WITH NEGATIVE PRESSURE AND INSTILLATION OF PEROXIDE PYRUVIC ACID=


==Organization Name==

[[:Category:3M INNOVATIVE PROPERTIES COMPANY|3M INNOVATIVE PROPERTIES COMPANY]]


[[Category:3M INNOVATIVE PROPERTIES COMPANY]]

==Inventor(s)==

[[:Category:Shannon C. Ingram of San Antonio TX (US)|Shannon C. Ingram of San Antonio TX (US)]][[Category:Shannon C. Ingram of San Antonio TX (US)]]

[[:Category:Christopher Allen Carroll of San Antonio TX (US)|Christopher Allen Carroll of San Antonio TX (US)]][[Category:Christopher Allen Carroll of San Antonio TX (US)]]

==SYSTEM AND METHODS FOR THE TREATMENT OF WOUNDS WITH NEGATIVE PRESSURE AND INSTILLATION OF PEROXIDE PYRUVIC ACID - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18536739 titled 'SYSTEM AND METHODS FOR THE TREATMENT OF WOUNDS WITH NEGATIVE PRESSURE AND INSTILLATION OF PEROXIDE PYRUVIC ACID

==Simplified Explanation==

The patent application describes a system and method for treating a tissue site using an antimicrobial solution comprising peroxy α-keto carboxylic acid, such as peroxy pyruvic acid, delivered to the tissue interface. The system includes a dressing, a solution source, and a negative-pressure source.

* The system includes a dressing that contacts the tissue site and provides a fluid seal between the therapeutic environment and the external environment.
* The solution source is fluidly coupled to the dressing and delivers the antimicrobial solution to the tissue interface.
* The negative-pressure source is fluidly coupled to the dressing and provides negative pressure to the therapeutic environment after delivering the antimicrobial fluid.

== Potential Applications ==
This technology could be applied in medical settings for treating wounds, infections, and other tissue sites that require antimicrobial treatment.

== Problems Solved ==
This technology helps in effectively delivering antimicrobial solutions to tissue sites while maintaining a sterile environment and providing negative pressure for optimal healing.

== Benefits ==
The benefits of this technology include improved wound healing, reduced risk of infections, and enhanced treatment outcomes for patients.

== Potential Commercial Applications ==
Potential commercial applications of this technology could include medical device companies, wound care clinics, hospitals, and healthcare facilities.

== Possible Prior Art ==
One possible prior art could be the use of negative-pressure wound therapy systems without the specific antimicrobial solution described in this patent application.

=== Unanswered Questions ===

== How does this technology compare to traditional wound care methods? ==
This article does not provide a direct comparison between this technology and traditional wound care methods. 

== What are the potential limitations or drawbacks of this technology? ==
The article does not address any potential limitations or drawbacks of this technology.


==Original Abstract Submitted==

In one example embodiment, a system for treating a tissue site is disclosed comprising a dressing adapted to contact the tissue site and provide a fluid seal between a therapeutic environment and a local external environment, and a solution source fluidly coupled to the dressing and adapted to deliver an antimicrobial solution comprising a peroxy α-keto carboxylic acid, such as peroxy pyruvic acid, to the tissue interface. The system may further comprise a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial fluid to the therapeutic environment. In another example embodiment, a method for treating a tissue site is disclosed comprising positioning a tissue interface to contact the tissue site, covering the tissue interface and the tissue site with a drape to provide a fluid seal between the therapeutic environment and the local external environment, and delivering an antimicrobial solution comprising peroxy α-keto carboxylic acid to the therapeutic environment before providing negative pressure to the therapeutic environment.



[[Category:A61M1/00]]
[[Category:A61F13/00]]
[[Category:A61K31/327]]